Stanford University
Showing 3,301-3,310 of 37,039 Results
-
Nawal Maria Boukli
Affiliate, Neurosurgery
BioDr. Nawal Boukli’s research focuses on understanding how cells transition from adaptive to maladaptive stress responses, with a central emphasis on endoplasmic reticulum (ER) stress, unfolded protein response (UPR) signaling, and GRP78 as a master regulator of cell fate and survival. Her work has defined critical mechanistic links between GRP78-driven stress adaptation, metabolic reprogramming, and therapeutic resistance in glioblastoma (GBM), while advancing GRP78 as a translational therapeutic target through antibody-based anti-GRP78 strategies designed to disrupt tumor survival pathways.
Her broader research program integrates molecular biology, quantitative multi-omics, cancer biology, and NeuroHIV to uncover stress-driven mechanisms underlying disease progression. In parallel, her NeuroHIV studies investigate how HIV-1 gp120 induces maladaptive ER stress responses that alter astrocyte–neuron communication, promote synaptic vulnerability, and contribute to neurodegenerative processes. Collectively, her work bridges cancer and neurodegeneration through a unifying framework centered on proteostasis disruption and chronic stress signaling.
In her project at Stanford University, awarded by The NIH Brain Initiative, Dr. Boukli is extending her research program using advanced spatial omics and neurobiology approaches to define astrocyte-specific ER stress domains and map how gp120-driven stress signaling becomes spatially organized within intact neural systems. This work aims to identify spatially resolved therapeutic targets and advance high-impact translational neuroscience studies.
Dr. Boukli is also recognized for her innovative teaching, scientific leadership, and commitment to mentorship. She has mentored more than 32 master’s students, 8 Ph.D. students, and numerous undergraduate trainees, while developing student-centered scientific training and mentoring initiatives. Following her election to the Association of Biomolecular Resource Facilities Executive Board in 2019, she launched the organization’s first annual speed-mentoring initiative in 2020. She additionally serves as a reviewer for the National Institutes of Health Center for Scientific Review, including study sections focused on cancer therapeutics and biomarker development.
Selected Peer-Reviewed Publications:
https://pubmed.ncbi.nlm.nih.gov/?term=nawal+boukli&sort=pubdate -
Ruxandra Boul
Lecturer
Current Research and Scholarly InterestsTimes Series Econometrics, International Finance and Monetary Policy
-
Adam Bouland
Assistant Professor of Computer Science
BioAdam Bouland is an Assistant Professor of Computer Science. His research focuses on quantum computing theory and connections between computational complexity and physics. Please see http://theory.stanford.edu/~abouland/ for details.
-
Donna M. Bouley, DVM, PhD
Professor of Comparative Medicine at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsResearch interests: ocular pathology, host-pathogen interactions in infectious disease, infectious disease in frogs, phenotypic characterization of tg and ko mice, histopathology of minimally-invasive radiological ablation techniques (focused ultrasound, cryoablation).
-
Timothy A. Bouley
Managing Director for Biological Solutions, Food, and Agriculture, Sustainability Accelerator
BioTimothy A. Bouley, MD, MSc, MA is Managing Director for Biological Solutions, Food, and Agriculture at the Stanford Doerr School of Sustainability. He is responsible for leading the strategy and implementation of life science-related ‘Flagship Destinations,’ accelerating Stanford research into scalable technology and policy solutions.
Dr. Bouley has spent more than 20 years working across biotechnology, medicine, food systems, and the environment. In 2020, he founded and served as CEO of BioFeyn, a life science company based at Harvard, translating biomedical innovation in nanoparticle and stability science to improve the health and sustainability of farmed Norwegian salmon and animal agriculture. In recent years he has also worked to develop and support biological innovations in eDNA and genomics, oral vaccines, tissue engineering, and others with a particular focus on applied benefit for environmental sustainability.
From 2011 – 2018, Timothy was at the World Bank where he established several of the first international programs in Planetary Health: founding the World Bank program on Climate Change and Health; launching the new field of Climate-Smart Healthcare; and serving as the originating author for the first UN-World Bank framework on One Health. Operationally, this work supported lending throughout Africa, Asia, and the Pacific, deploying technology-focused innovation and finance in environment, infectious disease, and agriculture. He led numerous publications, including the five-part 'Investing in Climate and Health' series and 'Framework for Strengthening Human, Animal, and Environmental Public Health Systems.'
He has written and lectured widely on the relationship of human health to the environment and serves as a regular advisor to international organizations, governments, financial institutions, industry, and start-ups. He has held fellowships with the US National Academy of Sciences, Rockefeller Foundation, University of Exeter, and University of Edinburgh. He holds degrees in biology, bioethics, geography, and medicine.
